Health CareStill being tested

Pfizer (PFE)

Foghorn reads the news on Pfizer and calls up or down only when a story is strong enough to move the stock, so most days there's no call. Every call is locked before the market reacts and graded here once its time is up.

Last close $30.50 on Fri, Oct 30 (IEX)

Calls for the next trading day0 of 1right, 0% of 1 call where the stock moved
Calls for the next 5 trading days—No graded calls for the next 5 trading days yet

Graded calls on PFE

Most recently judged first. Calls appear here once they're graded, and once every other call on the same news is graded too.
  • Judged Oct 8PFEPfizerCalled Up · next dayhow sure: a bit better than evenThe news: Pfizer's Tukysa approved for front-line breast cancer (PFE)The stock fell 0.6%Result: WrongLocked Oct 7, 3:47 PM ET , before its first judged close
    Fingerprint 2ea59b…000430b22ea59be736424b23ee175bf1a3fc602e9c4874e1ea01b112be3e809a000430b2

General market commentary, made the same way for everyone. It isn't investment advice or a recommendation to buy or sell PFE, and past accuracy does not promise future results.